Search

Author/Creator Roux, Flavien

1. Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial. Issue 16 (December 2015)

Authors:
Cortés, Javier; Dieras, Véronique; Ro, Jungsil; Barriere, Jérôme; Bachelot, Thomas; Hurvitz, Sara; Le Rhun, Emilie; Espié, Marc; Kim, Sung-Bae; Schneeweiss, Andreas; Sohn, Joo Hyuk; Nabholtz, Jean-Marc; Kellokumpu-Lehtinen, Pirkko-Liisa; Taguchi, Julie; Piacentini, Federico; Ciruelos, Eva; Bono, ...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 16(2015)
Page Start:
1700
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Empagliflozin as add-on to metformin plus sulphonylurea in patients with type 2 diabetes. Issue 1 (October 2015)

Authors:
Haering, Hans-Ulrich; Merker, Ludwig; Christiansen, Anita Vedel; Roux, Flavien; Salsali, Afshin; Kim, Gabriel; Meinicke, Thomas; Woerle, Hans J.; Broedl, Uli C.; on behalf of the EMPA-REG EXTEND™ METSU investigators
Journal:
Diabetes research and clinical practice
Issue:
Volume 110:Issue 1(2015)
Page Start:
82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial. Issue 1 (December 2015)

Authors:
Roden, Michael; Merker, Ludwig; Christiansen, Anita; Roux, Flavien; Salsali, Afshin; Kim, Gabriel; Stella, Peter; Woerle, Hans; Broedl, Uli
Journal:
Cardiovascular diabetology
Issue:
Volume 14:Issue 1(2015)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗